Noverant Selects Sequence, Inc. as a Life Science Channel Partner
(firmenpresse) - RALEIGH, NC -- (Marketwired) -- 06/04/13 -- Noverant is pleased to announce that it has selected Sequence, Inc. as a major channel partner. Under the non-exclusive, long term agreement, Sequence will lead the sales, marketing and account management efforts in a number of industries, initially focused on pharmaceutical, biotech, and medical device industries.
Commenting on the major alliance, Dr. Frank Gozzo, president and CEO of Noverant, stated, "Noverant has enjoyed 6 consecutive years of strategic growth and is now prepared to take our unique services to the next level through qualified channel partners. Sequence has highly-qualified subject matter experts who work on-site with diverse clients in the life science industry, and so the synergy of their consultants with our technology makes good business sense."
Michael Putnam, president and CEO of Sequence, stated, "With over 11 years of hands-on experience in the life science industry, we have a keen awareness of the operational needs of our clients. After careful due diligence, we selected Noverant for their proven technology, genuine customer-driven approach and unique ability to provide a highly-scalable, device-independent information, training and compliance management platform."
About Sequence
Sequence is a leader in providing quality and compliance consulting services to the Pharmaceutical, Biotech, and other regulated industries. For more information, visit
About Noverant
Noverant Inc. (): Noverant, Inc. is a global leader providing information, training and compliance management services for training, licensing, compliance, and auditing that conform with regulatory agency requirements for organizations in both the public and private sectors. Whether a secure, hosted solution ASP model or in an in-house solution under the administration of the client's own IT group, Noverant's compliance engine can satisfy 100 percent of an organization's training requirements, including those monitored by agencies such as the FDA, FAA, SEC, DOT and others.
For more information, call (919) 825-5613 or visit the website at .
Noverant, Inc.
PO Box 98084
Raleigh NC 27624-8084
919 825 5613 (Tel)
888 383-7316 (Fax)
Info:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.06.2013 - 05:00 Uhr
Sprache: Deutsch
News-ID 1233328
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
RALEIGH, NC
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 145 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Noverant Selects Sequence, Inc. as a Life Science Channel Partner
"
steht unter der journalistisch-redaktionellen Verantwortung von
Noverant, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
